Also trades as: TCBPW (NASDAQ) · $vol 0M
TCBP NASDAQ
TC Biopharm (Holdings) Plc
1W: +63.3%
1M: -69.8%
3M: -93.8%
1Y: -99.8%
3Y: -100.0%
$0.50
Last traded 2025-04-17 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
$0
-100.0% ▼
Operating Income
-$14M
-17.8% ▼
Net Income
-$6M
-349.7% ▼
EPS (Diluted)
$-9.56
+50.0% ▲
EBITDA
-$14M
-20.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $3M | $2M | $2M | $4M | $0 |
| YoY Growth | +0.0% | -42.3% | +0.0% | +94.3% | -100.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $3M | $2M | $2M | $4M | $0 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | — |
| R&D Expenses | $9M | $7M | $6M | $8M | $8M |
| SG&A Expenses | $3M | $2M | $3M | $9M | $7M |
| Operating Expenses | $10M | $8M | $14M | $125K | $7M |
| Operating Income | -$7M | -$7M | -$7M | -$12M | -$14M |
| Operating Margin | -193.8% | -348.1% | -368.3% | -314.3% | — |
| Interest Expense | $275K | $292K | $3M | $7M | $0 |
| Income Before Tax | -$7M | -$7M | -$15M | -$3M | -$7M |
| Tax Expense | -$826K | -$1M | -$1M | -$2M | -$1M |
| Net Income | -$6M | -$5M | -$14M | -$1M | -$6M |
| Net Margin | -177.1% | -275.8% | -686.1% | -34.2% | — |
| EPS (Diluted) | $-138.00 | $-124.00 | $-82488.00 | $-19.12 | $-9.56 |
| EBITDA | -$6M | -$5M | -$11M | $4M | -$14M |
| Shares Outstanding | 56116 | 56116 | 39058 | 68719 | 617840 |